Market Cap | 165.93M | P/E | - | EPS this Y | 25.60% | Ern Qtrly Grth | - |
Income | -17.98M | Forward P/E | -10.38 | EPS next Y | 9.00% | 50D Avg Chg | -4.00% |
Sales | 28.07M | PEG | -0.55 | EPS past 5Y | - | 200D Avg Chg | -22.00% |
Dividend | N/A | Price/Book | 5.09 | EPS next 5Y | 30.00% | 52W High Chg | -60.00% |
Recommedations | 1.70 | Quick Ratio | 2.24 | Shares Outstanding | 27.60M | 52W Low Chg | 8.00% |
Insider Own | 7.85% | ROA | -23.17% | Shares Float | 25.24M | Beta | 1.12 |
Inst Own | 30.30% | ROE | -60.40% | Shares Shorted/Prior | 717.76K/799.67K | Price | 6.75 |
Gross Margin | 59.85% | Profit Margin | -64.06% | Avg. Volume | 177,711 | Target Price | 11.83 |
Oper. Margin | -60.31% | Earnings Date | Nov 7 | Volume | 89,146 | Change | -2.32% |
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Lake Street | Buy | Aug 27, 24 |
Stifel | Buy | Mar 13, 24 |
Stifel | Buy | Oct 24, 23 |
Lake Street | Buy | Aug 9, 23 |
Lake Street | Buy | Mar 18, 21 |
B. Riley Securities | Buy | Jul 17, 20 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Piferi Peter G. | Chief Operating Offi.. Chief Operating Officer | Aug 20 | Option | 3.47 | 8,929 | 30,984 | 68,168 | 08/20/21 |